Sciact
  • EN
  • RU

New deoxycholic acid derived tyrosyl-dna phosphodiesterase 1 inhibitors also inhibit tyrosyl-dna phosphodiesterase 2 Научная публикация

Журнал Molecules
, E-ISSN: 1420-3049
Вых. Данные Год: 2022, Том: 27, Номер: 1, Номер статьи : 72, Страниц : DOI: 10.3390/molecules27010072
Ключевые слова Amide; Cancer; Deoxycholic acid; Molecular modeling; Oxadiazoles; TDP1 inhibitor; TDP2 inhibitor; Tumor
Авторы Salomatina O.V. 1 , Dyrkheeva N.S. 2 , Popadyuk I.I. 1 , Zakharenko A.L. 2 , Ilina E.S. 2 , Komarova N.I. 1 , Reynisson J. 3 , Salakhutdinov N.F. 1 , Lavrik O.I. 2 , Volcho K.P. 1
Организации
1 N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SB RAS, 9, Lavrent’ev Ave, Novosibirsk, 630090, Russian Federation
2 Institute of Chemical Biology and Fundamental Medicine, SB RAS, 8, Lavrent’ev Ave, Novosibirsk, 630090, Russian Federation
3 School of Pharmacy and Bioengineering, Keele University, Staffordshire, ST5 5BG, United Kingdom

Реферат: A series of deoxycholic acid (DCA) amides containing benzyl ether groups on the steroid core were tested against the tyrosyl-DNA phosphodiesterase 1 (TDP1) and 2 (TDP2) enzymes. In addition, 1,2,4-and 1,3,4-oxadiazole derivatives were synthesized to study the linker influence between a para-bromophenyl moiety and the steroid scaffold. The DCA derivatives demonstrated promising inhibitory activity against TDP1 with IC50 in the submicromolar range. Furthermore, the amides and the 1,3,4-oxadiazole derivatives inhibited the TDP2 enzyme but at substantially higher concentration. Tryptamide 5 and para-bromoanilide 8 derivatives containing benzyloxy substituent at the C-3 position and non-substituted hydroxy group at C-12 on the DCA scaffold inhibited both TDP1 and TDP2 as well as enhanced the cytotoxicity of topotecan in non-toxic concentration in vitro. According to molecular modeling, ligand 5 is anchored into the catalytic pocket of TDP1 by one hydrogen bond to the backbone of Gly458 as well as by π–π stacking between the indolyl rings of the ligand and Tyr590, resulting in excellent activity. It can therefore be concluded that these derivatives contribute to the development of specific TDP1 and TDP2 inhibitors for adjuvant therapy against cancer in combination with topoisomerase poisons. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Библиографическая ссылка: Salomatina O.V. , Dyrkheeva N.S. , Popadyuk I.I. , Zakharenko A.L. , Ilina E.S. , Komarova N.I. , Reynisson J. , Salakhutdinov N.F. , Lavrik O.I. , Volcho K.P.
New deoxycholic acid derived tyrosyl-dna phosphodiesterase 1 inhibitors also inhibit tyrosyl-dna phosphodiesterase 2
Molecules. 2022. V.27. N1. 72 . DOI: 10.3390/molecules27010072 WOS Scopus РИНЦ OpenAlex
Даты:
Поступила в редакцию: 18 нояб. 2021 г.
Принята к публикации: 21 дек. 2021 г.
Опубликована online: 23 дек. 2021 г.
Идентификаторы БД:
Web of science: WOS:000741699500001
Scopus: 2-s2.0-85121745314
РИНЦ: 47549342
OpenAlex: W4200404596
Цитирование в БД:
БД Цитирований
Scopus 7
РИНЦ 7
Web of science 10
OpenAlex 12
Альметрики: